Analysed 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) News Sources
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
01-07-2026
yahoo.com
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
08-07-2026
yahoo.com
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026
29-07-2026
yahoo.com
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
30-07-2026
yahoo.com
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15-04-2026
yahoo.com
What is the current price of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?
The current price of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is $0.031.
60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) absolute price change since previous trading day?
The absolute price change of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) since the previous trading day is $-0.0057.
60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) percentage price change since previous trading day?
The percentage price change of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) since the previous trading day is -15.5313%.
What is the most recent average sentiment score for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?
The most recent average sentiment score for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is 50 out of 100.
What is the most recent average sentiment for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?
The most recent sentiment for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is .
SEC-8K** Filing Available For 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.